Evidence map›Paper›PMID 26246457›Full record

ArticleDiabetes care2015

Environmentally Driven Increases in Type 2 Diabetes and Obesity in Pima Indians and Non-Pimas in Mexico Over a 15-Year Period: The Maycoba Project.

Julian Esparza-Romero, Mauro E Valencia, Rene Urquidez-Romero, Lisa S Chaudhari, Robert L Hanson, William C Knowler, Eric Ravussin, Peter H Bennett, Leslie O Schulz

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Diabetes care, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Julian Esparza-RomeroDepartamento de Nutrición Pública y Salud, Coordinación de Nutrición, Centro de Investigación en Alimentación y Desarrollo A.C., Hermosillo, Sonora, México.
Mauro E ValenciaDepartamento de Nutrición Pública y Salud, Coordinación de Nutrición, Centro de Investigación en Alimentación y Desarrollo A.C., Hermosillo, Sonora, México.
Rene Urquidez-RomeroDepartamento de Nutrición Pública y Salud, Coordinación de Nutrición, Centro de Investigación en Alimentación y Desarrollo A.C., Hermosillo, Sonora, México.
Lisa S ChaudhariCollege of Health and Human Services, Northern Arizona University, Flagstaff, AZ.
Robert L HansonPhoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ rhanson@phx.niddk.nih.gov.
William C KnowlerPhoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ.
Eric RavussinPennington Biomedical Research Center, Baton Rouge, LA.
Peter H BennettPhoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, AZ.
Leslie O SchulzCollege of Health and Human Services, Northern Arizona University, Flagstaff, AZ leslie.schulz@nau.edu.
Centro de Investigación en Alimentación y Desarrollo · MXNational Institutes of Health · USNorthern Arizona University · USNational Institute of Diabetes and Digestive and Kidney Diseases · USPennington Biomedical Research Center · US

Funding

Diabetes and Obesity in Mexican Pima IndiansZIADK075070 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI HANSON, ROBERT · 2012 to 2025
$2.9M
T2DM, Obesity in Mexican Pimas: Gene-Environment InteractionsR01DK082568 · NIDDK · NORTHERN ARIZONA UNIVERSITY · PI SCHULZ, LESLIE O. · 2009 to 2010
$1.4M
Intramural NIH HHSNIDDK NIH HHS 1R01DK082568-01A1NIDDK NIH HHS R01 DK082568
6 · The paper itself

Abstract

objectiveThe global epidemics of type 2 diabetes and obesity have been attributed to the interaction between lifestyle changes and genetic predisposition to these diseases. We compared the prevalences of type 2 diabetes and obesity in Mexican Pima Indians, presumed to have a high genetic predisposition to these diseases, to those in their non-Pima neighbors, both of whom over a 15-year period experienced a transition from a traditional to a more modern lifestyle. RESEARCH DESIGN AND

methodsPrevalence of diabetes, impaired fasting glucose, impaired glucose tolerance, and obesity in Mexican Pimas (n = 359) and non-Pima Mexicans (n = 251) were determined in 2010 using methods identical to those used in 1995.

resultsDuring this 15-year period, age-adjusted diabetes prevalence was unchanged in Pima men (5.8% in 1995 vs. 6.1% in 2010) yet increased in non-Pima men from 0.0 to 8.6% (P < 0.05). Diabetes prevalence tended to increase in both Pima women (9.4 vs. 13.4%) and non-Pima women (4.8 vs. 9.5%). Age-adjusted prevalence of obesity increased significantly in all groups (6.6 vs. 15.7% in Pima men; 8.5 vs. 20.5% in non-Pima men; 18.9. vs 36.3% in Pima women; 29.5 vs. 42.9% in non-Pima women).

conclusionsType 2 diabetes prevalence increased between 1995 and 2010 in non-Pima men, and to a lesser degree in women of both groups, but it did not increase in Pima men. Prevalence of obesity increased among Pimas and non-Pimas of both sexes. These changes occurred concomitantly with an environmental transition from a traditional to a more modernized lifestyle.

Indexed as

Life Change EventsAdultCross-Sectional StudiesDiabetes Mellitus, Type 2EnvironmentFemaleHumansIndians, North AmericanMaleMexicoMiddle AgedObesityPrevalenceYoung Adult

Identifiers

PMID26246457
PMCPMC4613913
OpenAlexW1754822772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.